Carregant...
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
BACKGROUND: Insulin is highly recommended for diabetes management in persons with liver cirrhosis. However, few studies have evaluated its long-term effects in these persons. We conducted this study to compare the risks of mortality, liver-related complications, and cardiovascular events in persons...
Guardat en:
| Publicat a: | BMC Gastroenterol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8199810/ https://ncbi.nlm.nih.gov/pubmed/34118892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01773-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|